More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/ELISA Kit for Glucagon Like Peptide 1 (GLP1)

ELISA Kit for Glucagon Like Peptide 1 (GLP1)

CEA804MI
Cloud-Clone Corp.
Product group Assays
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    Cloud-Clone Corp.
  • Product Name
    ELISA Kit for Glucagon Like Peptide 1 (GLP1)
  • Delivery Days Customer
    12
  • Assay Detection Range
    12.35-1,000pg/mL
  • Assay Precision
    Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Glucagon Like Peptide 1 (GLP1) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle ...
  • Assay Sensitivity
    The minimum detectable dose of this kit is typically less than 4.26pg/mL
  • Assay Specificity
    This assay has high sensitivity and excellent specificity for detection of Glucagon Like Peptide 1 (GLP1). No significant cross-reactivity or interference between Glucagon Like Peptide 1 (GLP1) and analogues was observed.
  • Assay Test Principle
    This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Glucagon Like Peptide 1 (GLP1) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled ...
  • Assay Time
    2h
  • Certification
    Research Use Only
  • UNSPSC
    41116158

References

  • Central GLP-1 contributes to improved cognitive function and brain glucose uptake after duodenum-jejunum bypass on obese and diabetic rats. Ruze R et al., 2021 Sep 1, Am J Physiol Endocrinol Metab
    Read more
  • Effect of oligofructose on resistance to postoperative high-fat diet-induced damage of metabolism in diabetic rats after sleeve gastrectomy. Zhong MW et al., 2021 Apr 15, World J Diabetes
    Read more
  • Downregulation of lncRNA MALAT1 contributes to renal functional improvement after duodenal-jejunal bypass in a diabetic rat model. Wu D et al., 2018 Aug, J Physiol Biochem
    Read more
  • Ileal Transposition Surgery Decreases Fat Mass and Improves Glucose Metabolism in Diabetic GK Rats: Possible Involvement of FGF21. Yan K et al., 2018, Front Physiol
    Read more
  • Selective Vagotomy Worsens Glucose Control After Ileal Transposition. Chen W et al., 2018 Aug, Obes Surg
    Read more
  • Deactivation of the NLRP3 inflammasome in infiltrating macrophages by duodenal-jejunal bypass surgery mediates improvement of beta cell function in type 2 diabetes. Wu D et al., 2018 Apr, Metabolism
    Read more
  • Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model. Dolo PR et al., 2018 May, Obes Surg
    Read more
  • The Effects of Duodenojejunal Omega Switch in Combination with High-Fat Diet and Control Diet on Incretins, Body Weight, and Glucose Tolerance in Sprague-Dawley Rats. Stygar D et al., 2018 Mar, Obes Surg
    Read more
  • Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. Balakumar M et al., 2018 Feb, Eur J Nutr
    Read more
  • Alterations in gut microbiota during remission and recurrence of diabetes after duodenal-jejunal bypass in rats. Zhong MW et al., 2016 Aug 7, World J Gastroenterol
    Read more